Xingxing Zang

10.8k total citations · 5 hit papers
118 papers, 8.0k citations indexed

About

Xingxing Zang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Xingxing Zang has authored 118 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Immunology, 71 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Xingxing Zang's work include Cancer Immunotherapy and Biomarkers (58 papers), Immunotherapy and Immune Responses (34 papers) and Immune Cell Function and Interaction (33 papers). Xingxing Zang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (58 papers), Immunotherapy and Immune Responses (34 papers) and Immune Cell Function and Interaction (33 papers). Xingxing Zang collaborates with scholars based in United States, China and United Kingdom. Xingxing Zang's co-authors include James P. Allison, Kim C. Ohaegbulam, Rick M. Maizels, Amer Assal, Eszter Lázár‐Molnár, Élodie Picarda, Yu Yao, Murali Janakiram, P’ng Loke and Jordan M. Chinai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Xingxing Zang

116 papers receiving 7.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

2003 695 citations Xingxing Zang, James P. Allison et al. profile →
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway

2014 654 citations Kim C. Ohaegbulam, Xingxing Zang et al. profile →
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy

2016 402 citations Élodie Picarda, Kim C. Ohaegbulam et al. Clinical Cancer Research profile →
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

2007 324 citations Xingxing Zang, James P. Allison et al. Proceedings of the National Academy of Sciences profile →
Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance

2021 225 citations Phillip M. Galbo, Xingxing Zang et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingxing Zang United States	45	4.6k	4.3k	1.6k	1.0k	626	118	8.0k
Lori Fitz United States	29	6.4k 1.4×	4.2k 1.0×	1.9k 1.2×	693 0.7×	380 0.6×	45	9.9k
Raffaella Bonecchi Italy	38	6.6k 1.4×	4.5k 1.0×	1.6k 1.0×	571 0.6×	448 0.7×	83	9.3k
Adrian F. Ochsenbein Switzerland	44	4.2k 0.9×	1.8k 0.4×	2.0k 1.2×	425 0.4×	356 0.6×	126	7.5k
Jane L. Grogan United States	34	4.7k 1.0×	2.5k 0.6×	1.0k 0.6×	327 0.3×	231 0.4×	60	6.7k
Sanjiv A. Luther Switzerland	44	7.6k 1.7×	3.7k 0.8×	1.6k 1.0×	360 0.4×	348 0.6×	82	10.2k
Raphael Clynes United States	47	6.2k 1.4×	2.7k 0.6×	2.9k 1.8×	374 0.4×	261 0.4×	99	11.2k
Hisaya Akiba Japan	53	8.3k 1.8×	3.4k 0.8×	2.0k 1.2×	347 0.3×	587 0.9×	126	10.8k
Rosanne Spolski United States	50	10.2k 2.2×	3.4k 0.8×	1.7k 1.0×	300 0.3×	453 0.7×	90	13.5k
William Vermi Italy	54	8.5k 1.9×	3.4k 0.8×	2.2k 1.4×	845 0.8×	735 1.2×	157	12.3k
Beatriz M. Carreno United States	40	8.4k 1.8×	5.6k 1.3×	2.1k 1.3×	796 0.8×	488 0.8×	75	11.3k

Countries citing papers authored by Xingxing Zang

Since Specialization

Citations

This map shows the geographic impact of Xingxing Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingxing Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingxing Zang more than expected).

Fields of papers citing papers by Xingxing Zang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingxing Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingxing Zang. The network helps show where Xingxing Zang may publish in the future.

Co-authorship network of co-authors of Xingxing Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Xingxing Zang. A scholar is included among the top collaborators of Xingxing Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingxing Zang. Xingxing Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inocencio, Julio, Stefan Mitrasinovic, Mohammad Asad, et al.. (2024). Immune checkpoint pathways in glioblastoma: a diverse and evolving landscape. Frontiers in Immunology. 15. 1424396–1424396. 3 indexed citations

Galbo, Phillip M., Joanne Xiu, Soma Sengupta, et al.. (2024). VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma. Cancers. 16(15). 2629–2629. 4 indexed citations

Galbo, Phillip M., Wei Yao, Wei Cui, et al.. (2024). TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors. Science Advances. 10(19). eadk1857–eadk1857. 8 indexed citations

Wang, Hao, R. Alejandro Sica, Gurbakhash Kaur, et al.. (2024). TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. Nature Communications. 15(1). 11–11. 32 indexed citations

Picarda, Élodie, Phillip M. Galbo, Haihong Zong, et al.. (2022). The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development. Science Advances. 8(17). eabm7012–eabm7012. 20 indexed citations

Akhmetzyanova, Ilseyar, Phillip M. Galbo, Anastasia N. Tikhonova, et al.. (2021). Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα. Blood Advances. 5(18). 3592–3608. 25 indexed citations

Zhou, Qianghua, Kaiwen Li, Yiming Lai, et al.. (2021). B7 score and T cell infiltration stratify immune status in prostate cancer. Journal for ImmunoTherapy of Cancer. 9(8). e002455–e002455. 31 indexed citations

Galbo, Phillip M., Xingxing Zang, & Deyou Zheng. (2021). Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance. Clinical Cancer Research. 27(9). 2636–2647. 225 indexed citations breakdown →

Yao, Wei, Xiaoxin Ren, Phillip M. Galbo, et al.. (2021). KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. Science Immunology. 6(61). 65 indexed citations

10.

Chung, Elaine Y., Urvi A. Shah, Yongqiang Wei, et al.. (2019). PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma. Clinical Cancer Research. 25(12). 3589–3601. 17 indexed citations

11.

Guan, Fangxia, Tuanjie Huang, Xinxin Wang, et al.. (2019). The TRIM protein Mitsugumin 53 enhances survival and therapeutic efficacy of stem cells in murine traumatic brain injury. Stem Cell Research & Therapy. 10(1). 352–352. 48 indexed citations

12.

Ying, Le, Feng Yan, Liang Yu, et al.. (2018). PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers. OncoImmunology. 7(6). e1433520–e1433520. 31 indexed citations

13.

Yao, Yu, Hongxing Ye, Zengxin Qi, et al.. (2016). B7-H4(B7x)–Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients. Clinical Cancer Research. 22(11). 2778–2790. 148 indexed citations

14.

Liu, Wei, et al.. (2016). Clinical outcome of various regimens of gonadotropin-releasing hormone analogues after conservative surgery in patients with endometriosis. 9(10). 19935–19943. 1 indexed citations

15.

Janakiram, Murali, Jordan M. Chinai, Susan Fineberg, et al.. (2014). Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein. Clinical Cancer Research. 21(10). 2359–2366. 131 indexed citations

16.

Scandiuzzi, Lisa, Walid Beghdadi, Éric Daugas, et al.. (2010). Mouse Mast Cell Protease-4 Deteriorates Renal Function by Contributing to Inflammation and Fibrosis in Immune Complex-Mediated Glomerulonephritis. The Journal of Immunology. 185(1). 624–633. 56 indexed citations

17.

Loke, P’ng, Iain J. Gallagher, Meera G. Nair, et al.. (2007). Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection. The Journal of Immunology. 179(6). 3926–3936. 212 indexed citations

18.

Loke, P’ng, Xingxing Zang, Rebecca Waitz, et al.. (2005). Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection. Proceedings of the National Academy of Sciences. 102(28). 9872–9877. 20 indexed citations

19.

Falcone, Franco H., P’ng Loke, Xingxing Zang, et al.. (2001). A Brugia malayi Homolog of Macrophage Migration Inhibitory Factor Reveals an Important Link Between Macrophages and Eosinophil Recruitment During Nematode Infection. The Journal of Immunology. 167(9). 5348–5354. 107 indexed citations

20.

Zang, Xingxing, Agnes Kurniawan, Paul Gray, et al.. (2000). The Serpin Secreted by Brugia malayi Microfilariae, Bm-SPN-2, Elicits Strong, but Short-Lived, Immune Responses in Mice and Humans. The Journal of Immunology. 165(9). 5161–5169. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact